Skip to main content

<span>局部麻醉软膏含有利多卡因,按照《防毒包装法》(PPPA)的规定,包装必须防止儿童开启。但是该软膏包装不能防止儿童开启,对幼儿构成中毒风险。</span>

  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Package Front
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Code, UPC and Batch Number
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Expiration Date
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream – Side View
Name of Product:
局部麻醉软膏含有利多卡因,按照《防毒包装法》(PPPA)的规定,包装必须防止儿童开启。但是该软膏包装不能防止儿童开启,对幼儿构成中毒风险。
Riesgo:

局部麻醉软膏含有利多卡因,按照《防毒包装法》(PPPA)的规定,包装必须防止儿童开启。但是该软膏包装不能防止儿童开启,对幼儿构成中毒风险。

Remedio:
Refund
Recall Date:
January 14, 2021

Detalles del retiro

Fabricación en:
China
Número del retiro:
21-719
Choose Your Recall Emails Get Notified About Each Recall via Email.
About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually. CPSC’s work to ensure the safety of consumer products has contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years. Federal law bars any person from selling products subject to a publicly announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.
For lifesaving information:
SaferProducts.gov